HIPPOCRATES RESEARCH / OUR EXPERTISE
Integrated support across clinical development, real-world evidence and medical devices. Explore the expertise behind each research journey.
Explore our expertise ↓02 / YOUR RESEARCH, SUPPORTED
Explore how our expertise supports your clinical development journey.
Early development
Turn a clinical question into a clear development plan, with scientific, regulatory and operational expertise working together.
Discuss your studyOUR RESEARCH PORTFOLIO
Study design, methodology and statistical planning support early clinical development. Phase II and proof-of-concept experience informs go/no-go decisions, while full programme management connects execution, risk mitigation, timelines and budgets through post-marketing research.
Observational research complements evidence available at marketing authorisation. HR supports post-authorisation safety studies, surveillance, cohort and case-control studies, and registries for drugs and medical devices.
Pre-market and post-market clinical investigations support devices across risk classes. Capabilities include clinical investigations for CE marking, post-market clinical follow-up and clinical evaluation of software as a medical device.
Clinical studies support evidence on safety, efficacy and product claims. HR helps manufacturers address methodological questions and develop evidence that can be communicated through scientific publications.
Studies are conducted with dermatologists, paediatricians and ophthalmologists, including projects involving sensitive populations. Clinical data support the assessment and substantiation of dermocosmetic product claims.
SERVICES IN DETAIL
From feasibility to final reporting, our services can support individual project needs or a connected development programme.
Literature research, regulatory review and consultation with key opinion leaders and specialist centres inform feasibility. Site questionnaires, protocol development and scientific interactions with competent authorities support study planning.
Data management is delivered in-house, while statistics and pharmacovigilance are provided together with qualified partners.